Donald E. Cutlip

56.3k total citations · 17 hit papers
253 papers, 29.8k citations indexed

About

Donald E. Cutlip is a scholar working on Surgery, Cardiology and Cardiovascular Medicine and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Donald E. Cutlip has authored 253 papers receiving a total of 29.8k indexed citations (citations by other indexed papers that have themselves been cited), including 200 papers in Surgery, 178 papers in Cardiology and Cardiovascular Medicine and 93 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Donald E. Cutlip's work include Coronary Interventions and Diagnostics (184 papers), Cardiac Imaging and Diagnostics (90 papers) and Acute Myocardial Infarction Research (78 papers). Donald E. Cutlip is often cited by papers focused on Coronary Interventions and Diagnostics (184 papers), Cardiac Imaging and Diagnostics (90 papers) and Acute Myocardial Infarction Research (78 papers). Donald E. Cutlip collaborates with scholars based in United States, Netherlands and France. Donald E. Cutlip's co-authors include Laura Mauri, Roxana Mehran, Jeffrey J. Popma, Richard E. Kuntz, Kalon K.L. Ho, Pascal Vranckx, Mitchell W. Krucoff, Patrick W. Serruys, Philippe Gabríel Steg and David J. Cohen and has published in prestigious journals such as New England Journal of Medicine, The Lancet and JAMA.

In The Last Decade

Donald E. Cutlip

247 papers receiving 28.9k citations

Hit Papers

Clinical End Points in Coronary Stent Trials 1998 2026 2007 2016 2007 2011 2004 1998 2007 1000 2.0k 3.0k 4.0k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Clinical End Points in Coronary Stent Trials
    2007 4.2k citations Donald E. Cutlip, David J. Cohen et al. Circulation profile →
  2. Standardized Bleeding Definitions for Cardiovascular Clinical Trials
    2011 2.9k citations Sunil V. Rao, Pascal Vranckx et al. Circulation profile →
  3. Protected Carotid-Artery Stenting versus Endarterectomy in High-Risk Patients
    2004 1.9k citations Richard E. Kuntz, Michael R. Jaff et al. profile →
  4. A Clinical Trial Comparing Three Antithrombotic-Drug Regimens after Coronary-Artery Stenting
    1998 1.2k citations Martin B. Leon, Donald S. Baim et al. profile →
  5. Safety and Efficacy of Sirolimus- and Paclitaxel-Eluting Coronary Stents
    2007 1.2k citations Gregg W. Stone, Ajay J. Kirtane et al. profile →
  6. Stent Thrombosis in Randomized Clinical Trials of Drug-Eluting Stents
    2007 1.1k citations Laura Mauri, Joseph M. Massaro et al. profile →
  7. Standardized endpoint definitions for transcatheter aortic valve implantation clinical trials: a consensus report from the Valve Academic Research Consortium
    2011 897 citations Donald E. Cutlip, Michael J. Mack et al. profile →
  8. Stent Thrombosis in the Modern Era
    2001 622 citations Donald E. Cutlip, Donald S. Baim et al. Circulation profile →
  9. Everolimus-Eluting versus Paclitaxel-Eluting Stents in Coronary Artery Disease
    2010 622 citations Gregg W. Stone, Ali A. Rizvi et al. profile →
  10. Development and Validation of a Prediction Rule for Benefit and Harm of Dual Antiplatelet Therapy Beyond 1 Year After Percutaneous Coronary Intervention
    2016 544 citations Robert W. Yeh, David J. Cohen et al. profile →
  11. Standardized Endpoint Definitions for Transcatheter Aortic Valve Implantation Clinical Trials
    2011 540 citations Martin B. Leon, Donald E. Cutlip et al. Journal of the American College of Cardiology profile →
  12. Long-Term Results of Carotid Stenting versus Endarterectomy in High-Risk Patients
    2008 533 citations Joseph M. Massaro, Donald E. Cutlip et al. profile →
  13. Stenting and Medical Therapy for Atherosclerotic Renal-Artery Stenosis
    2013 525 citations Timothy P. Murphy, Donald E. Cutlip et al. profile →
  14. Standardized End Point Definitions for Coronary Intervention Trials: The Academic Research Consortium-2 Consensus Document
    2018 514 citations Héctor M. García‐García, Eugène McFadden et al. Circulation profile →
  15. 2014 ACC/AHA Key Data Elements and Definitions for Cardiovascular Endpoint Events in Clinical Trials
    2014 506 citations Donald E. Cutlip, Michael R. Jaff et al. Circulation profile →
  16. A Pooled Analysis of Data Comparing Sirolimus-Eluting Stents with Bare-Metal Stents
    2007 499 citations Donald E. Cutlip, Patrick W. Serruys et al. profile →
  17. 2014 ACC/AHA Key Data Elements and Definitions for Cardiovascular Endpoint Events in Clinical Trials
    2014 380 citations Donald E. Cutlip, Michael R. Jaff et al. Journal of the American College of Cardiology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Donald E. Cutlip United States 68 22.8k 19.4k 8.7k 7.0k 3.3k 253 29.8k
George Dangas United States 88 19.0k 0.8× 16.8k 0.9× 6.8k 0.8× 8.0k 1.1× 1.8k 0.5× 669 29.6k
Richard E. Kuntz United States 71 14.8k 0.6× 16.5k 0.9× 8.2k 0.9× 7.3k 1.0× 2.1k 0.6× 249 23.9k
Lowell F. Satler United States 78 16.6k 0.7× 18.7k 1.0× 8.6k 1.0× 10.7k 1.5× 2.8k 0.8× 769 27.3k
Ajay J. Kirtane United States 72 16.5k 0.7× 12.0k 0.6× 4.4k 0.5× 5.3k 0.8× 3.2k 1.0× 564 23.4k
Ron Waksman United States 77 16.6k 0.7× 19.4k 1.0× 7.9k 0.9× 8.9k 1.3× 2.7k 0.8× 1.2k 29.2k
Jeffrey J. Popma United States 97 28.3k 1.2× 30.7k 1.6× 14.3k 1.6× 14.5k 2.1× 5.0k 1.5× 601 44.4k
Charanjit S. Rihal United States 88 21.3k 0.9× 13.0k 0.7× 5.7k 0.7× 7.5k 1.1× 4.4k 1.3× 586 28.9k
Alexandra J. Lansky United States 98 27.6k 1.2× 29.4k 1.5× 10.1k 1.2× 17.5k 2.5× 1.5k 0.4× 622 42.6k
Augusto D. Pichard United States 78 16.3k 0.7× 17.1k 0.9× 7.8k 0.9× 10.7k 1.5× 2.9k 0.9× 690 25.9k
Jeffrey W. Moses United States 82 18.2k 0.8× 21.3k 1.1× 8.2k 0.9× 10.6k 1.5× 1.6k 0.5× 531 30.2k

Countries citing papers authored by Donald E. Cutlip

Since Specialization
Citations

This map shows the geographic impact of Donald E. Cutlip's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Donald E. Cutlip with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Donald E. Cutlip more than expected).

Fields of papers citing papers by Donald E. Cutlip

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Donald E. Cutlip. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Donald E. Cutlip. The network helps show where Donald E. Cutlip may publish in the future.

Co-authorship network of co-authors of Donald E. Cutlip

This figure shows the co-authorship network connecting the top 25 collaborators of Donald E. Cutlip. A scholar is included among the top collaborators of Donald E. Cutlip based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Donald E. Cutlip. Donald E. Cutlip is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Kereiakes, Dean J., Robert L. Feldman, Alexander Ijsselmuiden, et al.. (2021). Safety and Effectiveness of the SVELTE Fixed-Wire and Rapid Exchange Bioresorbable-Polymer Sirolimus-Eluting Coronary Stent Systems for the Treatment of Atherosclerotic Lesions: Results of the OPTIMIZE Randomized Study. Circulation Cardiovascular Interventions. 14(9). e010609–e010609. 4 indexed citations
3.
Katritsis, Demosthenes G., Ioannis Pantos, Theodoros Zografos, et al.. (2020). Anatomic and Flow Characteristics of Left Anterior Descending Coronary Artery Angiographic Stenoses Predisposing to Myocardial Infarction. The American Journal of Cardiology. 141. 7–15. 1 indexed citations
4.
Spitzer, Ernest, Eugène McFadden, Pascal Vranckx, et al.. (2018). Defining Staged Procedures for Percutaneous Coronary Intervention Trials. JACC: Cardiovascular Interventions. 11(9). 823–832. 11 indexed citations
5.
Généreux, Philippe, Indulis Kumsārs, Joel E. Schneider, et al.. (2016). Dedicated Bifurcation Stent for the Treatment of Bifurcation Lesions Involving Large Side Branches. JACC: Cardiovascular Interventions. 9(13). 1338–1346. 15 indexed citations
6.
Murphy, Timothy P., Donald E. Cutlip, Judith G. Regensteiner, et al.. (2015). Supervised Exercise, Stent Revascularization, or Medical Therapy for Claudication Due to Aortoiliac Peripheral Artery Disease. Journal of the American College of Cardiology. 65(10). 999–1009. 166 indexed citations
7.
Rankin, Jamie, Elizabeth Geelhoed, Mark Newman, et al.. (2014). Evaluation of long-term clinical and health service outcomes following coronary artery revascularisation in Western Australia (WACARP): a population-based cohort study protocol. BMJ Open. 4(10). e006337–e006337. 7 indexed citations
8.
Vardi, Moshe, Jeremiah Perez, Paula J. Griffin, et al.. (2014). Usefulness of Postmarket Studies to Evaluate Long-Term Safety of Coronary Eluting Stents (from the ENDEAVOR and PROTECT Programs). The American Journal of Cardiology. 114(4). 528–533. 4 indexed citations
9.
10.
Blackshear, Joseph L., Donald E. Cutlip, Gary S. Roubin, et al.. (2011). Myocardial Infarction After Carotid Stenting and Endarterectomy. Circulation. 123(22). 2571–2578. 121 indexed citations
11.
Stone, Gregg W., Ali A. Rizvi, Krishnankutty Sudhir, et al.. (2011). Randomized Comparison of Everolimus- and Paclitaxel-Eluting Stents. Journal of the American College of Cardiology. 58(1). 19–25. 172 indexed citations
12.
Meredith, Ian T., Stephen G. Worthley, Robert Whitbourn, et al.. (2010). Long-term clinical outcomes with the next-generation Resolute Stent System: a report of the two-year follow-up from the RESOLUTE clinical trial. EuroIntervention. 5(6). 692–697. 30 indexed citations
13.
Kereiakes, Dean J., Donald E. Cutlip, Robert J. Applegate, et al.. (2010). Outcomes in Diabetic and Nondiabetic Patients Treated With Everolimus- or Paclitaxel-Eluting Stents. Journal of the American College of Cardiology. 56(25). 2084–2089. 67 indexed citations
14.
Latif, Faisal, Neal S. Kleiman, David J. Cohen, et al.. (2009). In-Hospital and 1-Year Outcomes Among Percutaneous Coronary Intervention Patients With Chronic Kidney Disease in the Era of Drug-Eluting Stents. JACC: Cardiovascular Interventions. 2(1). 37–45. 114 indexed citations
15.
Meredith, Ian T., John A. Ormiston, Robert Whitbourn, et al.. (2009). Five‐year clinical follow‐up after implantation of the endeavor zotarolimus‐eluting stent: ENDEAVOR I, first‐in‐human study. Catheterization and Cardiovascular Interventions. 74(7). 989–995. 17 indexed citations
16.
Kereiakes, Dean J., Mark Turco, Jeffrey A. Breall, et al.. (2008). A Novel Filter-Based Distal Embolic Protection Device for Percutaneous Intervention of Saphenous Vein Graft Lesions. JACC: Cardiovascular Interventions. 1(3). 248–257. 23 indexed citations
17.
Jeremias, Allen, Jorge Magallon, Ajay J. Kirtane, et al.. (2007). Comparison of Outcomes Using Sirolimus-Eluting Stenting in Diabetic Versus Nondiabetic Patients With Comparison of Insulin Versus Non–Insulin Therapy in the Diabetic Patients. The American Journal of Cardiology. 100(8). 1187–1191. 36 indexed citations
18.
Mauri, Laura, et al.. (2005). Robustness of Late Lumen Loss in Discriminating Drug-Eluting Stents Across Variable Observational and Randomized Trials. Circulation. 112(18). 2833–2839. 103 indexed citations
19.
Leon, Martin B., Donald S. Baim, Jeffrey J. Popma, et al.. (1999). A Clinical Trial Comparing Three Antithrombotic-Drug Regimens After Coronary Artery Stenting. Survey of Anesthesiology. 43(4). 194–195. 37 indexed citations
20.
Cutlip, Donald E., et al.. (1998). Cost-effectiveness of abciximab after coronary stenting: a decision-analytic model. Journal of the American College of Cardiology. 31. 51–51. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by George Dangas Breakdown of academic impact, for papers by Richard E. Kuntz Breakdown of academic impact, for papers by Lowell F. Satler Breakdown of academic impact, for papers by Ajay J. Kirtane Breakdown of academic impact, for papers by Ron Waksman Breakdown of academic impact, for papers by Jeffrey J. Popma Breakdown of academic impact, for papers by Charanjit S. Rihal Breakdown of academic impact, for papers by Alexandra J. Lansky Breakdown of academic impact, for papers by Augusto D. Pichard Breakdown of academic impact, for papers by Jeffrey W. Moses
Rankless by CCL
2026